Sympathetic activation in cardiovascular disease: evidence, clinical impact and therapeutic implications

被引:91
|
作者
Grassi, Guido [1 ,2 ]
Seravalle, Gino [3 ]
Mancia, Giuseppe [1 ,3 ]
机构
[1] Univ Milano Bicocca, Dipartimento Sci Salute, Med Clin, I-20052 Milan, Italy
[2] Sesto San Giovanni, IRCCS Multimed, Milan, Italy
[3] Ist Auxol Italiano, Milan, Italy
关键词
Congestive heart failure; drug treatment; hypertension; myocardial infarction; prognosis; sympathetic nervous system; AUTONOMIC NERVOUS-SYSTEM; BLOOD-PRESSURE; HEART-FAILURE; PLASMA NOREPINEPHRINE; BAROREFLEX FUNCTION; RENAL DENERVATION; SENSITIVITY; MOXONIDINE; MORTALITY; RESPONSES;
D O I
10.1111/eci.12553
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The sympathetic nervous exerts a key role in cardiovascular homeostasis control by regulating cardiac output, systemic vascular resistance, heart rate and blood pressure. Materials and methods Data collected during the past 30 years have unequivocally shown that in a considerable number of cardiovascular as well as noncardiovascular disease there is a marked activation of the sympathetic nervous system which exerts in the long-term period unfavourable haemodynamic, metabolic, cardiovascular and renal effects. Results This paper will review the current knowledge on the alterations in sympathetic function described in cardiovascular disease, with particular focus on hypertension, heart failure and myocardial infarction. Conclusions The consequences of the phoenomenon will be discussed together with its therapeutic implications. This will be done by examining the impact of nonpharmacological as well as pharmacological interventions on sympathetic cardiovascular drive. The effects of new invasive approaches, such as carotid baroreceptor stimulation as well as renal nerves ablation, will be also briefly discussed.
引用
收藏
页码:1367 / 1375
页数:9
相关论文
共 50 条
  • [21] Impact of age on cardiovascular risk: implications for cardiovascular disease management
    Tuomilehto, J
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (02) : 9 - 17
  • [22] Clinical Implications of Lipid Genetics for Cardiovascular Disease
    Strong A.
    Rader D.J.
    Current Cardiovascular Risk Reports, 2010, 4 (6) : 461 - 468
  • [23] Cardiovascular Involvement in Behcet Disease: Clinical Implications
    Yahalom, Malka
    Bloch, Lev
    Suleiman, Khaled
    Rosh, Bar
    Turgeman, Yoav
    INTERNATIONAL JOURNAL OF ANGIOLOGY, 2016, 25 (05) : E84 - E86
  • [24] The molecular genetics of cardiovascular disease: clinical implications
    Stephens, JW
    Humphries, SE
    JOURNAL OF INTERNAL MEDICINE, 2003, 253 (02) : 120 - 127
  • [25] Potential Clinical Implications of Senotherapies for Cardiovascular Disease
    Suda, Masayoshi
    Katsuumi, Goro
    Tchkonia, Tamar
    Kirkland, James L.
    Minamino, Tohru
    CIRCULATION JOURNAL, 2024, 88 (03) : 277 - 284
  • [26] Cardiovascular Disease in Masked Hypertension: Clinical Implications
    Choi, Cheol Ung
    Park, Chang Gyu
    CURRENT HYPERTENSION REVIEWS, 2010, 6 (04) : 254 - 259
  • [27] Neuroinflammation and Alzheimer disease: Clinical and therapeutic implications
    Eikelenboom, P
    Rozemuller, AJM
    Hoozemans, JJM
    Veerhuis, R
    van Gool, WA
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2000, 14 : S54 - S61
  • [28] Adynamic bone disease: clinical and therapeutic implications
    Frazao, Joao M.
    Martins, Patricia
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2009, 18 (04): : 303 - 307
  • [29] Sympathetic nervous activation in obesity and the metabolic syndrome-Causes, consequences and therapeutic implications
    Lambert, Gavin W.
    Straznicky, Nora E.
    Lambert, Elisabeth A.
    Dixon, John B.
    Schlaich, Markus P.
    PHARMACOLOGY & THERAPEUTICS, 2010, 126 (02) : 159 - 172
  • [30] Salt and cardiovascular disease: clinical and epidemiological evidence
    Gibbs, CR
    Lip, GYH
    Beevers, DG
    JOURNAL OF CARDIOVASCULAR RISK, 2000, 7 (01): : 9 - 13